Skip to main content

Table 1 Clinical characteristics of studying patients and the comparison between the stable treatment and unstable treatment group

From: Clinical factors associated with stable treatment of chronic constipation in Japanese patients

Ā 

Stable treatment

Unstable treatment

Total

p-value

(nā€‰=ā€‰82)

(nā€‰=ā€‰32)

(nā€‰=ā€‰114)

Age (meanā€‰Ā±ā€‰SD)

76.9ā€‰Ā±ā€‰13.3

78.2ā€‰Ā±ā€‰10.8

77.3ā€‰Ā±ā€‰12.7

0.65

Over 70 years old, n (%)

62 (75.6)

28 (87.5)

90 (78.9)

0.16

Male (n, %)

32 (39)

14 (43.8)

46 (40.4)

0.64

Obesity (n, %)

5 (6.1)

1 (3.1)

6 (5.3)

0.52

Underweight (n, %)

10 (12.2)

1 (3.1)

11 (9.6)

0.14

History of abdominal surgery (n, %)

38 (46.3)

16 (50)

54 (47.4)

0.73

Anemia (n, %)

43 (52.4)

12 (37.5)

55 (48.2)

0.15

Abnormal liver function (n, %)

10 (12.2)

6 (18.8)

16 (14)

0.37

Abnormal kidney function (n, %)

33 (40.2)

7 (21.9)

40 (35.1)

0.07

Diabetes mellitus (n, %)

32 (39)

8 (25)

40 (35.1)

0.16

Hypothyroidism (n, %)

7 (8.5)

3 (9.4)

10 (8.8)

0.89

Mental disorders (n, %)

13 (15.9)

2 (6.2)

15 (13.2)

0.17

Dementia (n, %)

4 (4.9)

2 (6.2)

6 (5.3)

0.77

Parkinsonā€™s disease (n, %)

1 (1.2)

0

1 (0.9)

0.53

Use of acid-suppressive drugs (n, %)

56 (68.3)

13 (40.6)

69 (60.5)

0.007

Use of prokinetic drugs (n, %)

11 (13.4)

2 (6.2)

13 (11.4)

0.28

Use of 3 or more types of laxatives (n, %)

12 (14.6)

7 (21.9)

19 (16.7)

0.35